119th Congress
H.R. 10150
Advancing Botanical Drug Development Act of 2026
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Lauren Boebert(R-CO)
- Introduced
- Aug 27, 2026
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (1)
Original cosponsors (1)
- Derrick Van Orden (R-WI)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend the Federal Food, Drug, and Cosmetic Act to provide a period of market exclusivity for botanical drugs, and for other purposes.
Latest action(Aug 27, 2026): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Aug 27, 2026 · House
Referred to the House Committee on Energy and Commerce. - Aug 27, 2026
Introduced in House